2025 Cabrini Research Forum banner with images only

2025 Cabrini Research Forum

1 – 30 November 2025

View and vote poster event

Cabrini Research Forum – November 2025

Welcome to the Cabrini Research Forum, a celebration of innovation, collaboration, and excellence in research and quality improvement across Cabrini!

Throughout November, explore a diverse range of research and quality improvement projects being led by researchers, clinicians, and our valued research partners. The posters are grouped into themed categories, showcasing the breadth of work being done to improve patient care, advance clinical practice, and contribute to healthcare knowledge.

This year’s event is open to all hospital staff, clinicians, researchers and the public, inviting everyone to discover the remarkable projects taking place across our organisation — and to have their say!

Cast your vote for the People’s Choice Award at the bottom of the page and go into the draw to win a prize. Your participation helps recognise and support the dedication and creativity of our teams.

Join us in celebrating the incredible work happening across Cabrini — from innovative clinical research to quality improvement initiatives — and be inspired by the difference we’re making together.

Explore. Vote. Celebrate research and quality improvement in healthcare!

Download a summary of all research posters

Explore the research and quality improvement projects by theme below

A patient ‘nudge’ letter did not reduce inpatient rehabilitation following joint replacement surgery: A randomised controlled trial with nested qualitative study.

– Jason Wallis

Communicating safe eating & drinking in dysphagia management: A retrospective audit.

– Madeleine Ebinger

Spontaneous swallowing in Parkinson’s Disease.

– Kendra Tabor

Improving malnutrition management at Cabrini Health.

– Kellie Wright

Ensuring Safe Patient Meals Through Packaging Reviews and Digital Menu Updates.

– Claire Deagan

Quantifying unopened packaged food waste at Cabrini Health: a pilot audit.

– Emma Pryn

Yoga vs Regular Exercise for Atrial Fibrillation: Design of the Yoga-AF Randomized Controlled Trial.

– Rose Crowley

Cardiac magnetic resonance left atrial ejection in atrial fibrillation and heart failure.

– Kenneth Cho

Recovered atrial fibrillation mediated cardiomyopathy: pharmacotherapy withdrawal cost- effectiveness.

– Kenneth Cho

The ceiling effect of heart failure pharmacotherapy in acute LV recovery patients with AF mediated cardiomyopathy prior to rhythm control.

– Kenneth Cho

Long term outcomes post ablation in patients with heart failure with reduced ejection fraction.

– Kenneth Cho

Assessing the utility of smartwatches in detecting transient bradyarrhythmia: The Brady-Watch study.

– Jeremy William

Does left atrial size predict ablation success in patients with persistent AF?

– Jeremy William

Antimicrobial prescribing patterns in the last 2 weeks of life at a single tertiary hospital.

– Athena Asmanis

Early vs Delayed Anticoagulant Initiation: venous thromboembolism risk after a total knee replacement/revision.

– Ruiqi Zhou

Misinterpreting Smartwatch Readings – A New Childhood Entity.

– Rachel Lim

17

Bazedixifene plus conjugated estrogen to treat menopausal depression – a pilot study.

– Eveline Mu

18

Quality Indicators of End-of-Life Care for Elderly Patients from Residential Aged Care Facilities.

– Archie Musafir

19

Uncovering the immunobiology and biomechanics of Human Fascia Lata as an autologous graft for Pelvic Organ Prolapse treatment..

– Lily Anthony

20

Retrospective analysis of an electronic supportive care screening tool utilised for Cabrini cancer patients.

– Jovana Marjanovic

21

Patient experience of an electronic supportive care screening tool utilised for Cabrini cancer patients: a prospective analysis.

– Jovana Marjanovic

22

Do clinical quality registries affect quality indicator outcomes? Victorian Lung Cancer Registry impacts on multi-disciplinary lung cancer meeting presentation.

– Gary Richardson

23

Exercise effects on lean body mass, muscle strength and physical function in patients with metastatic breast cancer.

– Eva Zopf

24

Spatial Transcriptomics Reveals Heterogeneity and Microenvironmental Shifts in Breast Cancer Subtypes and Metastatic Progression.

– Dilys Leung

25

A spatial atlas of colorectal cancer reveals the influence of stromal niches on tumour differentiation.

– Andrew Pattison

26

Mimicking cancer cell communications using assembloids as advanced models of breast cancer.

– Jasveena Kaur

27

A machine learning model to aid patient selection for focal treatment of prostate cancer.

– Yen Lim

28

The role of imaging after irreversible electroporation for prostate cancer.

– Yen Lim

29

Developing AI approaches to unravel factors that drive disease relapse in low risk, early-stage colorectal cancer.

– Charla Lu Chai

30

Prognostic factors of cancer recurrence in patients with low-risk colorectal cancer after surgery.

– Charla Lu Chai and Christine Georges

31

A clinician-friendly dynamic nomogram to evaluate the obesity paradox in colorectal cancer survival outcomes.

– Simon Wilkins

32

The complex and combined effect of gender, age, body mass index, and tumour site on postoperative colorectal cancer outcomes.

– Simon Wilkins

33

Association of comorbidity with recurrence and survival outcomes in colorectal cancer patients.

– Mohammad Asghari-Jafarabadi

34

Management of cT2N0M0 Esophageal Cancer: A systematic review and clinical practice guidelines.

– Yousif Eliya

35

D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial.

– Gary Richardson

36

A phase 1a study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors.

– Gary Richardson

37

Safety, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of HLX301, a bispecific antibody targeting PD-L1 and TIGIT, in patients with advanced solid tumors.

– Gary Richardson

38

First-in-human dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and initial efficacy of mRNA-LNP MT-302 in vivo CAR therapy in solid tumors.

– Gary Richardson

39

Amivantamab-chemotherapy in NSCLC with EGFR exon 20 insertions: Treatment crossover analysis from PAPILLON.

– Gary Richardson

40

Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC.

– Gary Richardson

41

Pharmacodynamic characterization of PRS-344/S095012, a PD-L1x4-1BB antibody-Anticalin fusion protein (Mabvalin), in a dose escalation study in patients with advanced solid tumors.

– Gary Richardson

Cabrini Research Forum 2025 Poster Voting